5'-(4-Cyanophenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbonitrile, 97%, 250mg

5-(4-Bromophenyl)-5-oxovaleric acid, 95.0%, 1g

3-Isopropoxy-5-(trifluoromethoxy)phenylboronic acid, 97%, 250mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 250mg

Ethyl 2-(4-Bromophenyl)-4-methylthiazole-5-carboxylate, 1g

2-(2-sec-butylphenoxy)propanoic acid, 95.0%, 5g

(S)-3-Hydroxymethyl-piperidine, 95.0%, 5g

2-[5-[(Acryloyloxy)methyl]-5-ethyl-1,3-dioxan-2-yl]-2-methylpropyl Acrylate (cis- and trans- mixture) (stabilized with MEHQ)>95.0%(qNMR)500g

ETHYL 7-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-2-CARBOXYLATE, 95.0%, 1g

tert-Butyl (4-(hydroxymethyl)pyridin-2-yl)carbamate, 95.0%, 10g

1-(3,5-Dimethoxyphenyl)-2,2,2-trifluoroethan-1-ol, 98%, 10g

6-TERT-BUTYL 4-ETHYL 2-(METHYLTHIO)-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-4,6(5H)-DICARBOXYLATE, 95.0%, 250mg

tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate, 95.0%, 250mg